Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
Lupo Center for Aesthetic and General Dermatology
🇺🇸
United States
Country
🇺🇸
United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News
Spread of PrabotulinumtoxinA-xvfs Versus OnabotulinumtoxinA in the Treatment of Forehead Rhytides
Early Phase 1
Completed
Conditions
Rhytides
Interventions
Drug: PrabotulinumtoxinA-Xvfs
Drug: OnabotulinumtoxinA
Subscribe
First Posted Date
2023-04-11
Last Posted Date
2024-03-13
Lead Sponsor
Lupo Center for Aesthetic and General Dermatology
Target Recruit Count
10
Registration Number
NCT05807412
Locations
🇺🇸
Lupo Center for Aesthetic and General Dermatology, New Orleans, Louisiana, United States
Subscribe
Prev
1
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy